CRL · 10-Q · 2026Q3 · Full report

Manufacturing Market Demand

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-11-04 · Importance 26 · Surprise 24

Manufacturing revenue was affected by the CDMO business sale, while demand-driven growth occurred in the retained businesses. Microbial Solutions revenue increased $24.7 million over the first nine months, driven primarily by higher demand for endotoxin testing reagents; third-quarter revenue in the business increased $7.2 million. Biologics Testing revenue increased $9.1 million over the first nine months and $6.6 million in the third quarter. The filing does not identify specific customers or geographic drivers for these increases.

Key facts

• Manufacturing Microbial Solutions revenue increased $24.7 million in the first nine months of 2026, driven primarily by higher demand for endotoxin testing reagents. source
• Manufacturing Microbial Solutions revenue increased $7.2 million in the third quarter, driven primarily by higher demand for endotoxin testing reagents. source